Kennedy Capital Management »

Peregrine Pharmaceuticals shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 342k 6.50
2023-09-30 $3.4M 359k 9.44
2023-06-30 $5.3M 381k 13.97
2023-03-31 $3.6M 194k 18.76
2022-12-31 $2.6M 191k 13.77
2022-09-30 $5.2M 273k 19.12
2022-06-30 $4.2M 273k 15.26
2022-03-31 $4.9M 241k 20.37
2021-12-31 $3.4M 117k 29.18
2021-09-30 $4.4M 203k 21.57
2021-06-30 $4.5M 176k 25.65
2021-03-31 $5.0M 273k 18.23
2020-12-31 $4.9M 422k 11.54
2020-09-30 $1.9M 255k 7.62
2020-06-30 $3.2M 489k 6.56
2020-03-31 $1.5M 291k 5.11
2019-12-31 $1.6M 214k 7.67
2018-06-30 $2.7M 692k 3.92
2018-03-31 $7.6M 2.6M 2.92